Enovis Research and Development Expenses 2010-2024 | ENOV

Enovis research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Enovis Annual Research and Development Expenses
(Millions of US $)
2023 $75
2022 $61
2021 $49
2020 $34
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $6
Enovis Quarterly Research and Development Expenses
(Millions of US $)
2024-09-30 $20
2024-06-30 $23
2024-03-31 $23
2023-12-31 $18
2023-09-30 $20
2023-06-30 $19
2023-03-31 $18
2022-12-31 $15
2022-09-30 $16
2022-06-30 $16
2022-03-31 $15
2021-12-31 $26
2021-09-30 $12
2021-06-30 $11
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30 $2
2010-06-30 $2
2010-03-31 $2
2009-12-31 $1
2009-09-30 $2
2009-06-30 $2
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.594B $1.707B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $11.384B 0.00
Inspire Medical Systems (INSP) United States $5.892B 183.76
Hims & Hers Health (HIMS) United States $5.028B 130.06
Axonics (AXNX) United States $3.600B 1760.50
IRhythm Technologies (IRTC) United States $2.707B 0.00
Privia Health (PRVA) United States $2.547B 213.00
Omnicell (OMCL) United States $2.306B 75.97
Azenta (AZTA) United States $2.190B 124.39
10x Genomics (TXG) United States $1.893B 0.00
Clover Health Investments (CLOV) United States $1.696B 0.00
Schrodinger (SDGR) United States $1.365B 0.00
Phreesia (PHR) United States $1.228B 0.00
Standard BioTools (LAB) United States $0.800B 0.00
Fulgent Genetics (FLGT) United States $0.589B 0.00
Butterfly Network (BFLY) United States $0.558B 0.00
Talkspace (TALK) United States $0.555B 0.00
Definitive Healthcare (DH) United States $0.500B 84.80
Health Catalyst (HCAT) United States $0.498B 0.00
Pulmonx (LUNG) United States $0.294B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.230B 0.00
TruBridge (TBRG) United States $0.203B 58.91
American Well (AMWL) United States $0.135B 0.00
P3 Health Partners (PIII) United States $0.134B 0.00
EUDA Health Holdings (EUDA) Singapore $0.108B 0.00
HeartBeam (BEAT) United States $0.068B 0.00
Future Health ESG (FHLT) United States $0.065B 0.00
111 (YI) China $0.059B 0.00
Zepp Health (ZEPP) China $0.049B 0.00
SHL Telemedicine (SHLT) Israel $0.045B 0.00
CareCloud (CCLD) United States $0.044B 0.00
Outset Medical (OM) United States $0.040B 0.00
Movano (MOVE) United States $0.029B 0.00
Bullfrog AI Holdings (BFRG) United States $0.021B 0.00
MSP Recovery (LIFW) United States $0.018B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Healthcare Triangle (HCTI) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00